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Vaccinations against infectious diseases are one of the
major achievements in medicine in the last century and
the most effective method for preventing infections. Con-
cern about safety of vaccinations has been heightened by
several reports of possible vaccine-induced autoimmune
phenomena following various vaccinations. So far no
study was able to show a casual connection between any
vaccine and autoimmune syndrome.
Few studies were published showing that induction of
autoantibodies following various vaccination is possible,
but without clinical significance. In few cases antibodies
after vaccination were elevated even 6 months after vacci-
nation. Induction of autantibodies, mainly antiphospho-
lipid antibodies, in selected apparently healthy individuals
was reported after influenza, hepatitis B and hepatitis
A vaccination.
Autoimmune manifestations reported have been only
temporally related to the respective vaccine. Guillian
Barre syndrome was described following vaccination
against influenza and few other vacines, multiple sclerosis
and arthritis were mainly reported after hepatitis B vacci-
nation. There are some evidence to suggest a connection
of reactive arthritis and rubella vaccine. Dermatomyositis
was described following hepatitis B, tuberculosis, influ-
enza and tetanus vaccinations. Recently a new syndrome
Autoimmune-Autoinflammatory syndrome induced by
adjuvants-ASIA has been described.
Highlights of lecture:
- autoimmune adverse events following vaccinations
is possible in selected individuals but the risk of auto-
immune disease after vaccination is, comparing to
advantages of vaccination, negligible.
- induction of autoantibodies in selected individuals
after vaccination has no clinical significance.
- new generation vaccine, mainly oriented on finding
safer and effective adjuvants, are needed. At present
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